MARY GLENN SHUART: Open Payments
NPI 1407904030 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 21 payments from 11 companies in 2025. Trend: 2023 $584 · 2024 $440 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 4 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $20 |
| Alkermes, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
Products named: REXULTI, Jornay PM, CAPLYTA, TRINTELLIX, COBENFY, Auvelity, Dyanavel XR, ARISTADA.
Industry payments across PA — which companies pay providers there.
